Arrowhead Pauses ARO-ENaC Phase 1/2 Clinical Study
Go back to Arrowhead Pauses ARO-ENaC Phase 1/2 Clinical Study| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 73.33 -0.53 (0.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $73.86 | 52 Week High | $8.22 | |||
| Open | $75.00 | 52 Week Low | $3.07 | |||
| Day High | $76.20 | P/E | N/A | |||
| Day Low | $69.71 | EPS | $-1.30 | |||
| Volume | 1,415,133 | |||||
